Page 8 - Retinal News Today

Opus to advance preclinical development programs for BEST1- and RHO-related retinal diseases Opus Genetics, a patient-first, clinical-stage gene therapy company

Diabetic retinopathy (DR), a primary cause of blindness in working-age people, affects about one-third of diabetic patients

Vabysmo achieved its primary endpoint of non-inferiority to aflibercept in RVO in the BALATON and COMINO clinical trials Vabysmo was generally well tolerated, with a safety profile consistent with previous

SOUTH SAN FRANCISCO (dpa-AFX) - Genentech, a member of Swiss drug major Roche Group (RHHBY), announced Thursday positive topline results from Phase III trials that showed Vabysmo improved vision

Egypt: Ocular alterations are more likely to occur in those with non-segmental vitiligo states a study published in the Australasian Journal of Dermatology.About 1% of people worldwide suffer from...

LBS-008 is Belite Bio’s orally administered tablet for early intervention to maintain the health of retinal tissue in Stargardt disease and Dry AMD patientsA 2-year Phase 2 trial in adolescent... | September 16, 2022

Therapy is a biosimilar of Lucentis which treats several serious retinal diseases across the European Union - News - PharmaTimes

A new discovery about jumping spiders could challenge some pretty hefty human assumptions about the cognitive abilities of arthropods.

ATLANTA, Aug. 10, 2022 -- Alimera Sciences, Inc. , a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and... | August 10, 2022

The ghost of further this act is an entire ally. is very proud of the weekend the herschel walker run for the senate in georgia challenged senator warner off was very articulate preacher all that stuff. he said to him why dont in august have a debate on this bill were he promptly said no chance hes not gonna do it i thought it was fascinating and i think it every republican candidate in the country should challenge their opponent to defend what i think is the tax increase 87,000 more internal re...